Where to start with this FUD, first we have 600 reps... Second, samples with how a many page black box waring pamphlet ?
You think doctors will listen to and support a company that knowingly sold a drug that caused cancer and destroyed lives for profit? 9 Billion dollar fine for selling poison.... I don't think so, the medical community has a very long memory, evidenced by the reluctance to script weight loss drugs over the Fen Phen mess.
Boston Convention and Exhibition Center
T-3028-OR: Early Effects of Lorcaserin (LOR) on Glycemic Parameters in Obese and Overweight Patients (pts) with Type 2 Diabetes Mellitus (T2D): A Retrospective Analysis of BLOOM-DM - Elisa Fabbrini, MD PhD; Randi Fain, MD; Alan Glicklich, MD, MBA; Yuhan Li, MS; William Shanahan, MD; William Soliman, PhD
10 days left before Obesity Week from Nov 2-7, just to much data to try and get through in such a short time. The studies have just been completed recently.
I don't think you copied me. I was addressing your timeline. I had a conversation with a key Eisai person. You can see that in my post history. He did not think they could get the Bel Phen data out during the upcoming meetings for the industry. Did not say no but stated a lot of data had to be analyzed and he was not sure that they could get it all done by the deadline. But did say that they had stated many times the results would be released by the end of the year and ended that statement with " expect it sooner rather then later"...
I don't think they will make it for Obesity Week.
Expect it sooner rather then later but might not make the big deadline. I posted this quote a couple weeks back.
Not enough volume to get us up there for today's options expiration. Max pain does not work all the time, we have seen here with this stock it has missed many times.
What makes you think the call sellers did not buy back their calls? I did... Also at these low prices how do you know shorts have not used the call options to cover the shares they could not buy back? We don't know where it will be by Jan 15 options expiration we have a few catalysts coming between now and then...
I think the Q over Q will show good growth in scripts more then 130% per year growth. Revenue will be up as well but I do believe this quarter we will see a major dip in the cash position... So while we will have a lot of positives, many on here and on the blogs will focus on the negative and cash burn will be the only negative I am predicting. That is an easy one... :-)
Hmmm, I was told scripts have been picking up steadily and that trend has continued... When the quarterly report comes we will see how well we have done Q over Q and Y over Y.
after that horrible miss last night. Looks like it will open down 26%...